Home  »  Industry   »  Geron Corporation (GERN): A Brand-New Prospect for...

Geron Corporation (GERN): A Brand-New Prospect for Investors

At the end of the latest market close, Geron Corporation (GERN) was valued at $2.68. In that particular session, Stock kicked-off at the price of $2.70 while reaching the peak value of $2.81 and lowest value recorded on the day was $2.685. The stock current value is $2.74.Recently in News on March 9, 2023, Geron to Announce Fourth Quarter and Full-Year 2022 Financial Results on March 16, 2023. Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it will release its fourth quarter and full-year 2022 financial results after the market closes on Thursday, March 16, 2023 via press release, which will be available on the Company’s website at www.geron.com/investors. Geron will host a conference call to discuss the financial results as well as upcoming milestones at 4:30 p.m. ET the same day. You can read further details here

Geron Corporation had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.84 on 01/04/23, with the lowest value was $1.01 for the same time period, recorded on 03/16/22.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


Geron Corporation (GERN) full year performance was 151.38%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Geron Corporation shares are logging -28.65% during the 52-week period from high price, and 171.29% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.01 and $3.84.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 5096535 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Geron Corporation (GERN) recorded performance in the market was 13.22%, having the revenues showcasing 20.18% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.09B, as it employees total of 69 workers.

Market experts do have their say about Geron Corporation (GERN)

During the last month, 0 analysts gave the Geron Corporation a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.59, with a change in the price was noted +0.36. In a similar fashion, Geron Corporation posted a movement of +15.13% for the period of last 100 days, recording 6,853,475 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for GERN is recording 0.47 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.35.

Technical breakdown of Geron Corporation (GERN)

Raw Stochastic average of Geron Corporation in the period of last 50 days is set at 37.14%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 62.00%. In the last 20 days, the company’s Stochastic %K was 42.81% and its Stochastic %D was recorded 31.68%.

Bearing in mind the latest performance of Geron Corporation, several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 13.22%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -1.44%, alongside a boost of 151.38% for the period of the last 12 months. The shares increased approximately by -1.79% in the 7-day charts and went up by -8.97% in the period of the last 30 days. Common stock shares were driven by 20.18% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts